Sequence of radiotherapy with tamoxifen in conservatively managed breast cancer does not affect local relapse rates

Journal of Clinical Oncology

Volumn 23, Issue 1, 2005, Pages 17-23

  Ahn, Peter H ^a   Vu, Ha Thanh ^a   Lannin, Donald ^a   Obedian, Edward ^a   DiGiovanna, Michael P ^a   Burtness, Barbara ^a   Haffty, Bruce G ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RELAPSE; CANCER STAGING; CONSERVATIVE TREATMENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RECURRENCE RISK; TREATMENT OUTCOME; BREAST TUMOR; COMPARATIVE STUDY; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; RADIOTHERAPY; RETROSPECTIVE STUDY; SEGMENTAL MASTECTOMY; SURVIVAL RATE; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TAMOXIFEN;

EID: 16644392632     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.09.048     Document Type: Article

References (38)

1. National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000. J Natl Cancer Inst Monogr 2001:5-15, 2001
2. Fisher B, Anderson S, Redmond CK, et al: Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333:1456-1461, 1995
3. Veronesi U: NIH consensus meeting on early breast cancer. Eur J Cancer 26:843-844, 1990
4. Veronesi U, Marubini E, Mariani L, et al: Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial. Ann Oncol 12:997-1003, 2001
5. Fisher B, Anderson S, Tan-Chiu E, et al: Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-23. J Clin Oncol 19:931-942, 2001
6. Fisher B, Redmond C, Poisson R, et al: Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 320:822-828, 1989
7. Fowble B: Ipsilateral breast tumor recurrence following breast-conserving surgery for early-stage invasive cancer. Acta Oncol 38:9-17, 1999 (suppl 13)
8. Haffty BG: Who's on first? Sequencing chemotherapy and radiation therapy in conservatively managed node-negative breast cancer. Cancer J Sci Am 5:147-149, 1999
9. Haffty BG, Fischer D, Rose M, et al: Prognostic factors for local recurrence in the conservatively treated breast cancer patient: A cautious interpretation of the data. J Clin Oncol 9:997-1003, 1991
10. Haffty BG, Wilmarth L, Wilson L, et al: Adjuvant systemic chemotherapy and hormonal therapy: Effect on local recurrence in the conservatively treated breast cancer patient. Cancer 73:2543-2548, 1994
11. Recht A, Come SE, Henderson IC, et al: The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med 334:1356-1361, 1996
12. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases: Anglian Breast Cancer Study Group. Br J Cancer 83:1301-8130, 2000
13. Tamoxifen for early breast cancer: An overview of the randomised trials-Early Breast Cancer Trialists' Collaborative Group. Lancet 351:1451-1467, 1998
14. Fisher B, Costantino JP, Wickerham DL, et al: Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371-1388, 1998
15. Fowble B, Fein DA, Hanlon AL, et al: The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer. Int J Radiat Oncol Biol Phys 35:669-677, 1996
16. Narod SA, Brunet JS, Ghadirian P, et al: Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: A case-control study-Hereditary Breast Cancer Clinical Study Group. Lancet 356:1876-1881, 2000
17. Veronesi U, Marubini E, Del Vecchio M, et al: Local recurrences and distant metastases after conservative breast cancer treatments: Partly independent events. J Natl Cancer Inst 87:19-27, 1995
18. Recht A, Harris JR, Come SE: Sequencing of irradiation and chemotherapy for early-stage breast cancer. Oncology (Huntingt) 8:19-37, 1994
19. Buchholz TA, Hunt KK, Amosson CM, et al: Sequencing of chemotherapy and radiation in lymph node-negative breast cancer. Cancer J Sci Am 5:159-164, 1999
20. Buchholz TA, Austin-Seymour MM, Moe RE, et al: Effect of delay in radiation in the combined modality treatment of breast cancer. Int J Radiat Oncol Biol Phys 26:23-35, 1993
21. Wallgren A, Bernier J, Gelber RD, et al: Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer: International Breast Cancer Study Group. Int J Radiat Oncol Biol Phys 35:649-659, 1996
22. Albain KS, Green SJ, Ravdin PM, et al: Adjuvant chemohormonal therapy for primary breast cancer should be given sequential instead of concurrent: Initial results from Intergroup trial 0100 (SWOG-88-14). J Clin Oncol 21:37a, 2002 (suppl)
23. Hug V, Hortobagyi GN, Drewinko B, et al: Tamoxifen-citrate counteracts the antitumor effects of cytotoxic drugs in vitro. J Clin Oncol 3:1672-1677, 1985
24. Jakesz R, Hausmaninger H, Haider K, et al: Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer. J Clin Oncol 17:1701-1709, 1999
25. Kantorowitz DA, Thompson HJ, Furmanski P: Effect of conjoint administration of tamoxifen and high-dose radiation on the development of mammary carcinoma. Int J Radiat Oncol Biol Phys 26:89-94, 1993
26. Wazer DE, Tercilla OF, Lin PS, et al: Modulation in the radiosensitivity of MCF-7 human breast carcinoma cells by 17-beta-estradiol and tamoxifen. Br J Radiol 62:1079-1083, 1989
27. Paulsen GH, Strickert T, Marthinsen AB, et al: Changes in radiation sensitivity and steroid receptor content induced by hormonal agents and ionizing radiation in breast cancer cells in vitro. Acta Oncol 35:1011-1019, 1996
28. Villalobos M, Aranda M, Nunez MI, et al: Interaction between ionizing radiation, estrogens and antiestrogens in the modification of tumor microenvironment in estrogen dependent multicellular spheroids. Acta Oncol 34:413-417, 1995
29. Haffty BG, Fischer D, Fischer JJ: Regional nodal irradiation in the conservative treatment of breast cancer. Int J Radiat Oncol Biol Phys 19:859-865, 1990
30. Schmidt-Ullrich RK, Valerie K, Chan W, et al: Expression of oestrogen receptor and transforming growth factor-alpha in MCF-7 cells after exposure to fractionated irradiation. Int J Radiat Biol 61:405-415, 1992
31. Buchholz TA, Wazer DE: Molecular biology and genetics of breast cancer development: A clinical perspective. Semin Radiat Oncol 12:285-295, 2002
32. Wazer DE, Band V: Molecular and anatomic considerations in the pathogenesis of breast cancer. Radiat Oncol Investig 7:1-12, 1999
33. Hall EJ: Radiobiology for the Radiologist (ed 4). Philadelphia, JB Lippincott, 1994
34. Ellis PA, Saccani-Jotti G, Clarke R, et al: Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancer. Int J Cancer 72:608-613, 1997
35. Fisher B, Dignam J, Wolmark N, et al: Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. J Natl Cancer Inst 89:1673-1682, 1997
36. Recht A: Radiotherapy-chemotherapy integration in breast-conservation therapy. Front Radiat Ther Oncol 27:89-102, 1993
37. Pierce LJ, Hutchins L, Green SJ, et al: Sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer. J Clin Oncol 23:10.1200/JCO .2005.01.198
38. Harris EER, Christensen VJ, Hwang W-T, et al: The impact of concurrent versus sequential tamoxifen with radiation therapy in early-stage breast cancer patients undergoing breast conservation treatment. J Clin Oncol 23:10.1200/JCO.2005.09.056